检验医学与临床Issue(1)：35-36,38,3.DOI:10.3969/j.issn.1672-9455.2013.01.016
196株阴沟肠杆菌对抗菌药物的敏感性分析
Susceptibility analysis of 196 strains Enterobacter cloacae
杨山虹 1刘琪 1梁培松 1彭祖旺 1胡文波 1卢兰芬 1孙各琴1
作者信息
- 1. 中山大学附属中山市人民医院检验医学中心，广东中山 528400
- 折叠
摘要
Abstract
Objective To investigate the susceptibility of Enterobacter cloacae isolated from system and urine patients ,and to provide reference for clinical therapy .Methods The susceptibility (MIC) of 196 Enterobacter cloacae strains from blood ,urine and others were tested by broth microdilution test .Results The sensitive rate of ECL to Imipenem was about 96 .9% .The sensitive rate of piperacillin/Tazobactam ,ofloxacin ,ciprofloxacin ,gentamycin ,to-bramycin were about 60% -80% ,The sensitive rate of ceftazidime ,Azactam ,ceftriaxone ,piperacillin were about 40%-60% .The sensitive rate of ampicillin/sulbatam was 14 .3% .The sensitive rate of ampicillin and cefazolin were only 3 .6% and 1 .5% .The susceptibility rate of Enterobacter cloacae isolated from urine was a little higher than the strains isolated from blood to ampicillin/Sulbatam ,cefazolin .The susceptibility rate of Enterobacter cloacae isolated from urine was higher than the strains isolated from blood to ampicillin ,ceftazidime ,ceftiaxone ,ciprofloxacin ,genta-mycin ,imipenem ,ofloxacin ,azactam ,piperacillin、piperacillin / Tazobactam ,tobramycin .Conclusion The drug sus-ceptibility of Enterobacter cloacae causing systemic and urine infection is different .The available therapy project should be selected based on the resistance character .At present ,Imipenem is the active drug for treatment against the infection caused by Enterobacter cloacae .关键词
阴沟肠杆菌/抗菌药物/敏感性Key words
Enterobacter cloacae/antibiotics/drug susceptibility引用本文复制引用
杨山虹,刘琪,梁培松,彭祖旺,胡文波,卢兰芬,孙各琴..196株阴沟肠杆菌对抗菌药物的敏感性分析[J].检验医学与临床,2013,(1):35-36,38,3.
